School of Medical Sciences Neuroscience Program and Brain and Mind Centre, University of Sydney, New South Wales 2050, Australia.
School of Nursing and Brain Research Institute, University of California, Los Angeles, Los Angeles, California 90095.
J Neurosci. 2021 Nov 24;41(47):9794-9806. doi: 10.1523/JNEUROSCI.0806-21.2021. Epub 2021 Oct 25.
Pain perception can be powerfully influenced by an individual's expectations and beliefs. Although the cortical circuitry responsible for pain modulation has been thoroughly investigated, the brainstem pathways involved in the modulatory phenomena of placebo analgesia and nocebo hyperalgesia remain to be directly addressed. This study used ultra-high-field 7 tesla functional MRI (fMRI) to accurately resolve differences in brainstem circuitry present during the generation of placebo analgesia and nocebo hyperalgesia in healthy human participants ( = 25, 12 male). Over 2 successive days, through blinded application of altered thermal stimuli, participants were deceptively conditioned to believe that two inert creams labeled lidocaine (placebo) and capsaicin (nocebo) were acting to modulate their pain relative to a third Vaseline (control) cream. In a subsequent test phase, fMRI image sets were collected while participants were given identical noxious stimuli to all three cream sites. Pain intensity ratings were collected and placebo and nocebo responses determined. Brainstem-specific fMRI analysis revealed altered activity in key pain modulatory nuclei, including a disparate recruitment of the periaqueductal gray (PAG)-rostral ventromedial medulla (RVM) pathway when both greater placebo and nocebo effects were observed. Additionally, we found that placebo and nocebo responses differentially activated the parabrachial nucleus but overlapped in engagement of the substantia nigra and locus coeruleus. These data reveal that placebo and nocebo effects are generated through differential engagement of the PAG-RVM pathway, which in concert with other brainstem sites likely influences the experience of pain by modulating activity at the level of the dorsal horn. Understanding endogenous pain modulatory mechanisms would support development of effective clinical treatment strategies for both acute and chronic pain. Specific brainstem nuclei have long been known to play a central role in nociceptive modulation; however, because of the small size and complex organization of the nuclei, previous neuroimaging efforts have been limited in directly identifying how these subcortical networks interact during the development of antinociceptive and pro-nociceptive effects. We used ultra-high-field fMRI to resolve brainstem structures and measure signal change during placebo analgesia and nocebo hyperalgesia. We define overlapping and disparate brainstem circuitry responsible for altering pain perception. These findings extend our understanding of the detailed organization and function of discrete brainstem nuclei involved in pain processing and modulation.
疼痛感知可以受到个体的期望和信念的强烈影响。尽管负责疼痛调节的皮质电路已经得到了彻底的研究,但涉及安慰剂镇痛和反安慰剂痛觉过敏的调制现象的脑干通路仍有待直接解决。本研究使用超高场 7 特斯拉功能磁共振成像 (fMRI) 来准确分辨健康人类参与者在产生安慰剂镇痛和反安慰剂痛觉过敏时存在的脑干回路差异(n=25,12 名男性)。在连续两天的时间里,通过对改变的热刺激进行盲法应用,参与者被欺骗性地 Conditioning,使他们相信两种标记为利多卡因(安慰剂)和辣椒素(反安慰剂)的惰性乳膏相对于第三种凡士林(对照)乳膏能够调节他们的疼痛。在随后的测试阶段,当给参与者相同的有害刺激到所有三个乳膏部位时,收集 fMRI 图像集。收集疼痛强度评分并确定安慰剂和反安慰剂的反应。脑干特异性 fMRI 分析显示,在关键的疼痛调节核中,包括在观察到更大的安慰剂和反安慰剂作用时,不同程度地募集了导水管周围灰质(PAG)-腹内侧前脑髓(RVM)通路。此外,我们发现,当观察到更大的安慰剂和反安慰剂作用时,安慰剂和反安慰剂反应不同地激活了臂旁核,但在黑质和蓝斑的参与中重叠。这些数据表明,安慰剂和反安慰剂效应是通过 PAG-RVM 通路的不同参与产生的,该通路与其他脑干部位一起,可能通过调节背角的活动来影响疼痛的体验。了解内源性疼痛调节机制将支持急性和慢性疼痛的有效临床治疗策略的发展。已知特定的脑干核在伤害性调节中起着核心作用;然而,由于核的体积小且组织复杂,先前的神经影像学研究受到限制,无法直接确定这些皮质下网络在产生抗伤害性和促伤害性效应时如何相互作用。我们使用超高场 fMRI 来分辨脑干结构并测量安慰剂镇痛和反安慰剂痛觉过敏时的信号变化。我们定义了负责改变疼痛感知的重叠和不同的脑干回路。这些发现扩展了我们对参与疼痛处理和调节的离散脑干核的详细组织和功能的理解。
J Neurosci. 2017-3-1
Neuroimage. 2024-10-15
Neuroimage. 2015-5-15
J Neurosci. 2017-11-24
Neuroimage. 2016-1-1
Psychosom Med. 2021-1-1
Front Integr Neurosci. 2024-8-16
Neuroimage. 2021-2-1
Front Neurosci. 2020-1-31
Neuroimage. 2020-4-1